✦ LIBER ✦

High dose methotrexate with citrovorum factor in adult resistant lymphoma

✍ Scribed by Steven Turman; Morton Coleman; Richard T. Silver; Mark Pasmantier

Publisher: John Wiley and Sons
Year: 1977
Tongue: English
Weight: 470 KB
Volume: 40
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197712)40:6<2823::aid-cncr2820400612>3.0.co;2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose methotrexate with citrovorum f

High-dose methotrexate with citrovorum factor and vincristine in the treatment of malignant mesothelioma

✍ Nikolay V. Dimitrov; James Egner; Ernie Balcueva; Leif G. Suhrland 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 2 views

The incidence of malignant mesothelioma has increased greatly in the last 40 years. Current and recent past exposure to asbestos is expected to substantially increase this incidence. We report nine cases of malignant mesothelioma which temporarily responded to treatment with high-dose methotrexate-c

Oral high-dose methotrexate with citrovo

Oral high-dose methotrexate with citrovorum factor rescue in metastatic squamous cell carcinoma of the lung

✍ Karl Tornyos; Hiltrud Faust 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

Continuous infusion vincristine and bleo

Continuous infusion vincristine and bleomycin with high dose methotrexate for resistant non-Hodgkin's lymphoma

✍ Dickerman Hollister Jr; Richard T. Silver; Bruce Gordon; Morton Coleman 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

Sixteen patients with resistant non-Hodgkin's lymphoma were treated with continuous infusions of vincristine (1-2 mg/m2 daily X 2 days) and bleomycin (0.25 mg/kg bolus dose, then 0.25 mg/kg/daily X 5 days). Responding patients received high dose methotrexate (1500 mg/m2) with citrovorum rescue on da

Fractionated cyclophosphamide and back t

Fractionated cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (Snccl): A randomized trial of the pediatric oncology group

✍ Brecher, Martin L.; Schwenn, Molly R.; Coppes, Max J.; Bowman, W. Paul; Link, Mi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

## Background: The pediatric oncology group (pog) conducted a two-arm, randomized study for the treatment of children and adolescents with stage iii small, non-cleaved cell lymphoma (snccl). regimen a, based on the group's previous best treatment for this group of patients, included cyclophosphamid